Abbott's Big Gamble
Monday, December 19, 2011 - 01:20
in Mathematics & Economics
Firm will pay $400 million for Reata Pharmaceutical's preclinical drug candidates
Firm will pay $400 million for Reata Pharmaceutical's preclinical drug candidates